Building Initial Reserves: The Loading Phase For those new to Glutathione IV therapy or experiencing significant depletion, an initial loading phase is typically recommended
Changes that can affect you this year: In the below cases, you will be affected by coverage changes during the year: New generic drugs We may immediately remove a brand-name drug on our drug list if we are replacing it with a new generic drug that will appear on the same or lower cost-sharing tier and with the same or fewer restrictions
The Therapeutic Goods Administration's (TGA) warning covers the following glucagon-like peptide-1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and obesity: Semaglutide, sold as Ozempic, Wegovy Tirzepatide, sold as Mounjaro Dulaglutide, sold as Trulicity Liraglutide, sold as Saxenda The TGA said the products had the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION)
Bae, Sajin, et al
Comprehensive GH support enhances metabolic efficiency, insulin sensitivity, and cellular energy production
